Literature DB >> 17534945

Myopathy as a first symptom of Huntington's disease in a Marathon runner.

Christoph M Kosinski1, Christiane Schlangen, Frank N Gellerich, Zemfira Gizatullina, Markus Deschauer, Johannes Schiefer, Anne B Young, Georg Bernhard Landwehrmeyer, Klaus V Toyka, Bernd Sellhaus, Katrin S Lindenberg.   

Abstract

A semi professional marathon runner at risk for Huntington's disease (HD) (43 CAG repeats) developed signs of a slowly progressive myopathy with exercise-induced muscle fatigue, pain, elevated creatine kinase level, and worsening of his running performance many years before first signs of chorea were detected. Muscle biopsy displayed a mild myopathy with mitochondrial pathology including a complex IV deficiency and analysis of the patient's fibroblast culture demonstrated deficits in mitochondrial function. Challenging skeletal muscle by excessive training might have disclosed myopathy in HD even years before the appearance of other neurological symptoms. Copyright (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534945     DOI: 10.1002/mds.21550

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  38 in total

1.  Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.

Authors:  Rajnish K Chaturvedi; Noel Y Calingasan; Lichuan Yang; Thomas Hennessey; Ashu Johri; M Flint Beal
Journal:  Hum Mol Genet       Date:  2010-06-07       Impact factor: 6.150

Review 2.  Bridging animal and human models of exercise-induced brain plasticity.

Authors:  Michelle W Voss; Carmen Vivar; Arthur F Kramer; Henriette van Praag
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

Review 3.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

4.  Exercise effects in Huntington disease.

Authors:  Sebastian Frese; Jens A Petersen; Maria Ligon-Auer; Sandro Manuel Mueller; Violeta Mihaylova; Saskia M Gehrig; Veronika Kana; Elisabeth J Rushing; Evelyn Unterburger; Georg Kägi; Jean-Marc Burgunder; Marco Toigo; Hans H Jung
Journal:  J Neurol       Date:  2016-10-17       Impact factor: 4.849

5.  Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.

Authors:  Ahmad Khedraki; Eric J Reed; Shannon H Romer; Qingbo Wang; William Romine; Mark M Rich; Robert J Talmadge; Andrew A Voss
Journal:  J Neurosci       Date:  2017-07-19       Impact factor: 6.167

Review 6.  All about running: synaptic plasticity, growth factors and adult hippocampal neurogenesis.

Authors:  Carmen Vivar; Michelle C Potter; Henriette van Praag
Journal:  Curr Top Behav Neurosci       Date:  2013

7.  The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease.

Authors:  Jonathan H Fox; Teal Connor; Vanita Chopra; Kate Dorsey; Jibrin A Kama; Dorothee Bleckmann; Claudia Betschart; Daniel Hoyer; Stefan Frentzel; Marian Difiglia; Paolo Paganetti; Steven M Hersch
Journal:  Mol Neurodegener       Date:  2010-06-22       Impact factor: 14.195

8.  A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers.

Authors:  Jolanta Krzysztoń-Russjan; Daniel Zielonka; Joanna Jackiewicz; Sylwia Kuśmirek; Irena Bubko; Aneta Klimberg; Jerzy T Marcinkowski; Elżbieta L Anuszewska
Journal:  J Bioenerg Biomembr       Date:  2012-10-16       Impact factor: 2.945

Review 9.  PGC-1α, mitochondrial dysfunction, and Huntington's disease.

Authors:  Ashu Johri; Abhishek Chandra; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2013-04-19       Impact factor: 7.376

10.  Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.

Authors:  Hilary Moffitt; Graham D McPhail; Ben Woodman; Carl Hobbs; Gillian P Bates
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.